Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bupa Arabia is a Saudi public healthcare insurance company that provides cooperative health insurance for corporates, SMEs, families, and individuals in Saudi Arabia. Originally established in 1997 as a joint venture with Nazer Group and incorporated as a Saudi joint stock company in 2008, it is listed on the Saudi Exchange and operates as an associate business of Bupa Group. The company’s core business is underwriting and administering medical insurance, supported by digital member services, provider-network management, claims operations, and health management offerings. In recent years it has been expanding beyond insurance into broader healthcare delivery and digitally enabled care, including telehealth and integrated outpatient services through initiatives such as Bupa CareConnect. For a healthcare-focused analyst, Bupa Arabia is best viewed as a leading payer and health-services platform in Saudi Arabia rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bupa Arabia.